• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Life Sciences - Pharma | News, Analysis, Insights - HIT Consultant

Hurdle, CloudLIMS Partner to Augment Diagnostic Lab Capabilities

by Syed Hamza Sohail 02/15/2023 Leave a Comment

Hurdle, CloudLIMS Partner to Augment Diagnostic Lab Capabilities

What You Should Know: - Hurdle (a Chronomics Inc. brand), a global bio-infrastructure platform that powers end-to-end diagnostics for life sciences, labs and healthcare providers, and CloudLIMS, a leading SOC 2 compliant and ISO 9001:2015 certified lab informatics provider, announced today that the companies have entered into a strategic partnership marking the first integration between a Diagnostic as a Service (DaaS) platform and a Software-as-a-Service (SaaS) LIMS provider. - The
Read More

Faro Health Secures $20M to Streamline Smart Clinical Trials

by Fred Pennic 02/08/2023 Leave a Comment

Faro Health Secures $20M to Streamline Smart Clinical Trials

What You Should Know: - Faro Health, a cloud-computing company that is developing digital infrastructure for smart clinical trials raises $20M in Series A funding led by General Catalyst to help scale the digital transformation of clinical trials––essentially making it easier and quicker for drug developers to greatly reduce the cost and time of trials. - The round also included participation from previous investors Section 32, Polaris Partners, Zetta Ventures, and Northpond Ventures.
Read More

Why Researchers Should Explore New Apps of Machine Learning

by Michael Munsell, Director of Research at Panalgo 02/08/2023 Leave a Comment

Why Researchers Should Explore New Apps of Machine Learning

As the amount of real-world data (RWD) in the pharmaceutical industry continues to grow, so does the usage of machine learning (ML) to analyze that data and gain insights. In fact, in a recent survey, 95% of life sciences executives said they expect to utilize ML in the next few years to generate real-world evidence (RWE) from this data.  With such a large and growing volume of data available, researchers may be wondering how they can take advantage of all of it to enhance and expand the
Read More

2023’s Biggest Pharma Cybersecurity Threats to Watch

by JP Perez-Etchegoyen, CTO of Onapsis 02/03/2023 Leave a Comment

2023’s Biggest Pharma Threats to Watch

Due to the recent growth of the pharmaceutical industry, the value of highly-sensitive data stored in pharmaceutical systems and the degree of the potential damage that cyberattacks on the industry can cause, it is safe to say that pharma could be one of the most targeted industries by cybercriminals in 2023. Ransomware, phishing attacks, business applications and third-party vendors will be some of the biggest threats to this key vertical as we approach the new year. RansomwareThe threat of
Read More

How Chatbots Can Be the Next Best Thing in Healthcare

by Jason Warrelmann, VP, Global Services & Process Industries at UiPath 01/30/2023 Leave a Comment

3 Myths About Robotic Process Automation in Healthcare, Debunked

Today’s healthcare facilities are facing critical staffing problems. Over 19% of U.S. hospitals are experiencing staffing shortages, according to government data posted earlier this year. Caused primarily by the COVID-19 pandemic, nurses and doctors have left hospitals and healthcare clinics because of the dangerous, high-stress conditions. More recently, the U.S. saw rulings and changes that could affect an individual’s access to healthcare – driving more questions and concerns from patients
Read More

9 Executive Revenue Cycle Predictions/Trends to Watch in 2023

by Fred Pennic 01/23/2023 Leave a Comment

Executive Revenue Cycle Predictions/Trends

Nate Maslak, the co-founder/CEO of Ribbon Health Price Transparency: In 2022, we saw CMS’s Transparency in Coverage rule go into effect, requiring non-hospital entities like health plans and providers to publish publicly available rates for care. In 2023, we’ll see this price transparency data become more mainstream as it finally makes its way into the hands of patients, empowering them to find the best care for them, reevaluate their care choices, and shop around for the best possible care
Read More

Datavant Partners with Socially Determined to Optimize Social Risk on Patient Outcomes

by Jasmine Pennic 01/20/2023 Leave a Comment

Datavant Partners with Socially Determined to Optimize Social Risk on Patient Outcomes

What You Should Know: - Socially Determined, the social risk analytics and data company partners with Datavant, a company helping organizations securely connect health data. - The strategic partnership enables Socially Determined to provide curated, de-identified and linkable social risk data on the patient-level. This capability will empower life sciences organizations to comprehensively assess and systematically address the impact of social risk on health outcomes. Why It
Read More

Caris Life Sciences Raises $400M to Advance AI-Driven Molecular Profiling to Revolutionize Cancer Care

by Fred Pennic 01/19/2023 Leave a Comment

Caris Life Sciences and ConcertAI Partner to Accelerate Drug Development and Novel Research

What You Should Know: - Caris Life Sciences® (Caris), the a molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced today that the company has closed a senior secured term loan providing up to $400M in capital from OrbiMed and Braidwell. With this funding, Caris has raised approximately $1.7 billion in capital since 2018.  - Caris' comprehensive molecular profiling approach precisely analyzes DNA (Whole
Read More

8 Executive Pharmacy Predictions/Trends to Watch in 2023

by Fred Pennic 01/18/2023 Leave a Comment

Executive Pharmacy Predictions/Trends 2023

Frank Harvey, CEO at Surescripts Community pharmacists trusted to deliver care: In 2023, pharmacists will play an integral role as part of the team managing patient care for diseases like diabetes, hypertension, or multiple comorbidities. And to support this work, I predict that we will see more activity between payers, pharmacists, the government and technology organizations to ensure that pharmacists are able to perform these important activities and be reimbursed for their work. Greg
Read More

Why EHR Data Is Key to Gathering More Accurate Medical Assessments

by Jake Hochberg, Executive Director, Customer Insights at Arcadia 01/16/2023 Leave a Comment

Why EHR Data Is Key to Gathering More Accurate Medical Assessments

Patient data in electronic health records (EHRs) holds a wealth of insights that can enable health systems to better serve their patient populations.   However, data from EHRs is challenging because this data is messy due to the lack of standardization in how clinical data is collected, and often times valuable information is buried in unstructured fields such as notes. Additionally, EHR data is disconnected from EHR data at other sites of care resulting in an incomplete view of the
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 28
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |